Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses.

Hillaire ML, Vogelzang-van Trierum SE, Kreijtz JH, de Mutsert G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

J Gen Virol. 2013 Mar;94(Pt 3):583-92. doi: 10.1099/vir.0.048652-0. Epub 2012 Nov 14.

PMID:
23152369
2.

[Swine influenza virus: evolution mechanism and epidemic characterization--a review].

Qi X, Lu C.

Wei Sheng Wu Xue Bao. 2009 Sep;49(9):1138-45. Review. Chinese.

PMID:
20030049
3.

Genetic and antigenic evolution of swine influenza viruses in Europe and evaluation of their zoonotic potential.

Kuntz-Simon G, Madec F.

Zoonoses Public Health. 2009 Aug;56(6-7):310-25. doi: 10.1111/j.1863-2378.2009.01236.x. Review.

PMID:
19497089
4.

[Swine-origin influenza H1N1/California--passions and facts].

Gendon IuZ.

Zh Mikrobiol Epidemiol Immunobiol. 2010 Jul-Aug;(4):105-14. Review. Russian.

PMID:
20795393
5.

Immunity to seasonal and pandemic influenza A viruses.

Valkenburg SA, Rutigliano JA, Ellebedy AH, Doherty PC, Thomas PG, Kedzierska K.

Microbes Infect. 2011 May;13(5):489-501. doi: 10.1016/j.micinf.2011.01.007. Epub 2011 Feb 2. Review.

6.

Virus-specific T cells as correlate of (cross-)protective immunity against influenza.

Altenburg AF, Rimmelzwaan GF, de Vries RD.

Vaccine. 2015 Jan 15;33(4):500-6. doi: 10.1016/j.vaccine.2014.11.054. Epub 2014 Dec 9. Review.

PMID:
25498210
7.

The 2009 pandemic influenza virus: where did it come from, where is it now, and where is it going?

York I, Donis RO.

Curr Top Microbiol Immunol. 2013;370:241-57. doi: 10.1007/82_2012_221. Review.

PMID:
22638836
8.

Vaccine development for protecting swine against influenza virus.

Chen Q, Madson D, Miller CL, Harris DL.

Anim Health Res Rev. 2012 Dec;13(2):181-95. doi: 10.1017/S1466252312000175. Review.

PMID:
23253165
9.

Review: influenza virus in pigs.

Crisci E, Mussá T, Fraile L, Montoya M.

Mol Immunol. 2013 Oct;55(3-4):200-11. doi: 10.1016/j.molimm.2013.02.008. Epub 2013 Mar 21. Review.

PMID:
23523121
10.

Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses.

Guarner J, Falcón-Escobedo R.

Arch Med Res. 2009 Nov;40(8):655-61. doi: 10.1016/j.arcmed.2009.10.001. Epub 2010 Jan 6. Review.

PMID:
20304252
11.

Constraints, Drivers, and Implications of Influenza A Virus Reassortment.

Lowen AC.

Annu Rev Virol. 2017 Sep 29;4(1):105-121. doi: 10.1146/annurev-virology-101416-041726. Epub 2017 May 26. Review.

PMID:
28548881
12.

Dendritic cells and influenza A virus infection.

Waithman J, Mintern JD.

Virulence. 2012 Nov 15;3(7):603-8. doi: 10.4161/viru.21864. Epub 2012 Oct 17. Review.

13.

Emerging influenza viruses and the prospect of a universal influenza virus vaccine.

Krammer F.

Biotechnol J. 2015 May;10(5):690-701. doi: 10.1002/biot.201400393. Epub 2015 Mar 2. Review.

PMID:
25728134
14.

HA2 glycopolypeptide of influenza A virus and antiviral immunity.

Varečková E, Mucha V, Kostolanský F.

Acta Virol. 2013;57(2):247-56. Review.

PMID:
23600881
15.

Innate immune responses to influenza A H5N1: friend or foe?

Peiris JS, Cheung CY, Leung CY, Nicholls JM.

Trends Immunol. 2009 Dec;30(12):574-84. doi: 10.1016/j.it.2009.09.004. Epub 2009 Oct 26. Review.

16.

Human influenza viruses and CD8(+) T cell responses.

Grant EJ, Quiñones-Parra SM, Clemens EB, Kedzierska K.

Curr Opin Virol. 2016 Feb;16:132-142. doi: 10.1016/j.coviro.2016.01.016. Epub 2016 Mar 12. Review.

PMID:
26974887
17.

Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.

Hillaire ML, Osterhaus AD, Rimmelzwaan GF.

J Biomed Biotechnol. 2011;2011:939860. doi: 10.1155/2011/939860. Epub 2011 Oct 5. Review.

18.

Host response to influenza virus: protection versus immunopathology.

Peiris JS, Hui KP, Yen HL.

Curr Opin Immunol. 2010 Aug;22(4):475-81. doi: 10.1016/j.coi.2010.06.003. Epub 2010 Jun 30. Review.

19.

Clearance of influenza virus infections by T cells: risk of collateral damage?

Hillaire ML, Rimmelzwaan GF, Kreijtz JH.

Curr Opin Virol. 2013 Aug;3(4):430-7. doi: 10.1016/j.coviro.2013.05.002. Epub 2013 May 27. Review.

PMID:
23721864
20.

Low-pH Stability of Influenza A Virus Sialidase Contributing to Virus Replication and Pandemic.

Takahashi T, Suzuki T.

Biol Pharm Bull. 2015;38(6):817-26. doi: 10.1248/bpb.b15-00120. Review.

Supplemental Content

Support Center